NEW YORK, NY — One day after launching a campaign to unseat U.S. Senator Bob Menendez (D-N.J.), former Celgene CEO Bob Hugin, a Republican, visited CNBC to discuss his candidacy and pledge a focus on healthcare reform should he win in November.
“I’m going to go to Washington and I’m going to craft specific proposals to reform health care,” Hugin explained.
The former pharmaceutical industry titan also stood his ground when questioned on the pricing of Revlimid, noting that the multiple myeloma drug is helping those suffering with a difficult disease.
“I can’t speak for Celgene anymore,” he said. “But I can tell you, Revlimid is an incredibly valuable drug for patients. It is so important breakthrough therapy.”